Dentists can elevate their practice portfolio and offering to patients by joining the next generation of Invisalign providers

被引：0
|
作者：
不详
机构：
来源：
BRITISH DENTAL JOURNAL | 2023年 / 235卷 / 06期
关键词：
D O I：
10.1038/s41415-023-6370-z
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [41] A Better Real World Practice for ROS1 Positive NSCLC Patients, Driven by the Targeted Next Generation Sequencing(NGS) and the Targeted TKI
    Liang, Z.
    Zhang, Y.
    Yang, N.
    Li, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S483 - S484
  • [42] Next-Generation Manufacturing Protocols Enriching TSCMCAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
    Arcangeli, Silvia
    Falcone, Laura
    Camisa, Barbara
    De Girardi, Federica
    Biondi, Marta
    Giglio, Fabio
    Ciceri, Fabio
    Bonini, Chiara
    Bondanza, Attilio
    Casucci, Monica
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [43] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
    Ahn, Jae-Sook
    Kim, TaeHyung
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Jung, Seung-Yeon
    Song, Ga-Young
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, SeungHyun
    Lee, Ja-Yeon
    Park, Seong-Kyu
    Moon, Joon Ho
    Lee, Hui Young
    Kim, Kyoung Ha
    Cai, Yu
    Yi, Seong Yoon
    Novitzky-Basso, Igor
    Zhang, Zhaolei
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2021, 56 (05) : 1159 - 1170
  • [44] Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
    Jae-Sook Ahn
    TaeHyung Kim
    Sung-Hoon Jung
    Seo-Yeon Ahn
    Seung-Yeon Jung
    Ga-Young Song
    Mihee Kim
    Deok-Hwan Yang
    Je-Jung Lee
    SeungHyun Choi
    Ja-Yeon Lee
    Seong-Kyu Park
    Joon Ho Moon
    Hui Young Lee
    Kyoung Ha Kim
    Yu Cai
    Seong Yoon Yi
    Igor Novitzky-Basso
    Zhaolei Zhang
    Hyeoung-Joon Kim
    Dennis Dong Hwan Kim
    Bone Marrow Transplantation, 2021, 56 : 1159 - 1170
  • [45] Implementation of IgH/k Next Generation Sequencing for Multiple Myeloma Minimal Residual Disease monitoring: advantages in patients' management during daily clinical practice.
    Armuzzi, Silvia
    Martello, Marina
    Borsi, Enrica
    Solli, Vincenza
    Poletti, Andrea
    Vigliotta, Ilaria
    Taurisano, Barbara
    Pistis, Ignazia
    Mazzocchetti, Gaia
    Zamagni, Elena
    Pantani, Lucia
    Rocchi, Serena
    Mancuso, Katia
    Tacchetti, Paola
    Rizzello, Ilaria
    Cavo, Michele
    Terragna, Carolina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S58 - S58
  • [46] Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
    Kohlmann, A.
    Nadarajah, N.
    Alpermann, T.
    Grossmann, V.
    Schindela, S.
    Dicker, F.
    Roller, A.
    Kern, W.
    Haferlach, C.
    Schnittger, S.
    Haferlach, T.
    LEUKEMIA, 2014, 28 (01) : 129 - 137
  • [47] Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
    A Kohlmann
    N Nadarajah
    T Alpermann
    V Grossmann
    S Schindela
    F Dicker
    A Roller
    W Kern
    C Haferlach
    S Schnittger
    T Haferlach
    Leukemia, 2014, 28 : 129 - 137
  • [48] A NOVEL NEXT-GENERATION SEQUENCING BASED ASSAY FOR FLT3/ITD MUTATIONS IS SENSITIVE AND SPECIFIC AND CAN BE USED TO DETECT MINIMAL RESIDUAL DISEASE IN AML PATIENTS
    Levis, M.
    Miller, J.
    Xie, Z.
    McClain, V.
    Carson, A.
    Stenzel, T.
    HAEMATOLOGICA, 2016, 101 : 215 - 216
  • [49] Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing
    Ricardo Donners
    Ines Figueiredo
    Nina Tunariu
    Matthew Blackledge
    Dow-Mu Koh
    Maria de los Dolores Fenor de la Maza
    Khobe Chandran
    Johann S. de Bono
    Nicos Fotiadis
    European Radiology, 2022, 32 : 4647 - 4656
  • [50] Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing
    Donners, Ricardo
    Figueiredo, Ines
    Tunariu, Nina
    Blackledge, Matthew
    Koh, Dow-Mu
    de la Maza, Maria de los Dolores Fenor
    Chandran, Khobe
    de Bono, Johann S.
    Fotiadis, Nicos
    EUROPEAN RADIOLOGY, 2022, 32 (07) : 4647 - 4656
12345